{"product_id":"cjc-1295-ipamorelin","title":"CJC-1295 W\/IPAMORELIN NO DAC","description":"\u003cp\u003eCJC-1295 with Ipamorelin (No DAC) is a dual-peptide research blend combining a modified GHRH analogue with a selective GHS-R1a agonist, targeting two distinct points in the somatotropic axis. This is one of the most frequently investigated GH pathway blends in research settings.\u003c\/p\u003e\u003cp\u003eThe No DAC formulation provides a shorter half-life profile for research designs requiring pulsatile release modeling. Their combined use is studied for potential synergistic effects on GH pulse amplitude and frequency.\u003c\/p\u003e\u003ch4\u003eResearch Applications\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eDual-pathway GH secretion research (GHRH + GHS receptor)\u003c\/li\u003e\n\u003cli\u003ePulsatile GH release amplitude and frequency studies\u003c\/li\u003e\n\u003cli\u003eIGF-1 axis regulation and downstream signaling research\u003c\/li\u003e\n\u003cli\u003eBody composition and lean mass metabolism models\u003c\/li\u003e\n\u003cli\u003eRecovery and regenerative biology preclinical study designs\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003eKey Features\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eDual-compound GH pathway blend — No DAC formulation\u003c\/li\u003e\n\u003cli\u003eTargets GHRH receptor and GHS-R1a simultaneously\u003c\/li\u003e\n\u003cli\u003eResearch-grade purity, independently verified\u003c\/li\u003e\n\u003cli\u003eFor laboratory and investigational use only\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"JACE Research","offers":[{"title":"Default Title","offer_id":62898546180467,"sku":null,"price":60.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0846\/1683\/files\/IMG-9628.png?v=1785191927","url":"https:\/\/jaceresearch.com\/products\/cjc-1295-ipamorelin","provider":"Jace Research","version":"1.0","type":"link"}